Reviva Pharmaceuticals Holdings (RVPH) Net Equity Issued and Repurchased (2019 - 2026)
Reviva Pharmaceuticals Holdings (RVPH) recorded Net Equity Issued and Repurchased of $2.5 million in Q1 2026, up 936.8% from $241,125 a year earlier but down 62.9% from the prior quarter.
Powered by 
Analysis
Reviva Pharmaceuticals Holdings (RVPH) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends
For FY2025, Reviva Pharmaceuticals Holdings reported Net Equity Issued and Repurchased of $6.98 million.
- Annual Net Equity Issued and Repurchased has a three-year compound annual growth rate of 616.5% (FY2022 to FY2025).
- Across earlier years, Net Equity Issued and Repurchased came in at $149.00 in FY2024 (-100.0%), $5.68 million in FY2023 and $18,966 in FY2022.
- Quarterly Net Equity Issued and Repurchased has ranged from $35.00 in Q3 2024 to $6.73 million in Q4 2025 over the past five years.
- Per Business Quant, the preceding three quarters came in at $6.73 million (Q4 2025), $1.2 million (Q3 2025) and $1.5 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | - |
| 10 | Reviva Pharmaceuticals Holdings | 4.46 Mn | -82.75 Mn | - | -144,974.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -144,974.00 |
| Jun 30, 2026 | -93,827.00 |
| Mar 31, 2026 | 9.19 Mn |
| Dec 31, 2025 | -264,792.00 |
| Sep 30, 2025 | 10.66 Mn |
| Jun 30, 2025 | 10.39 Mn |
| Dec 31, 2024 | 16.64 Mn |
| Sep 30, 2024 | 3.75 Mn |
| Jun 30, 2024 | 2.81 Mn |
| Dec 31, 2023 | 27.49 Mn |
| Jun 30, 2023 | 5.66 Mn |
| Mar 31, 2023 | 19,593.00 |
| Dec 31, 2022 | 18,563.00 |
| Sep 30, 2022 | 7.77 Mn |
| Mar 31, 2022 | 70.00 |
| Dec 31, 2021 | 98,481.00 |
| Jun 30, 2021 | 31.50 Mn |
| Nov 30, 2020 | -109,130.00 |
| May 31, 2020 | -26.98 Mn |
| Feb 29, 2020 | 20.82 Mn |
API Access
Reviva Pharmaceuticals Holdings Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RVPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "RVPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RVPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();